Safety Data Sheet: Caffeine
Safety Data Sheet: Caffeine
Safety Data Sheet: Caffeine
1
Revision Date 27.09.2019
according to Regulation (EC) No. 1907/2006 Print Date 14.09.2020
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye
protection tested and approved under appropriate government standards such as
NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove
removal technique (without touching glove's outer surface) to avoid skin contact
with this product. Dispose of contaminated gloves after use in accordance with
applicable laws and good laboratory practices. Wash and dry hands.
The selected protective gloves have to satisfy the specifications of Regulation (EU)
2016/425 and the standard EN 374 derived from it.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail
[email protected], test method: EN374
If used in solution, or mixed with other substances, and under conditions which
differ from EN 374, contact the supplier of the CE approved gloves. This
recommendation is advisory only and must be evaluated by an industrial hygienist
and safety officer familiar with the specific situation of anticipated use by our
customers. It should not be construed as offering an approval for any specific use
scenario.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must
be selected according to the concentration and amount of the dangerous substance
at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle
respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU
EN 143) respirator cartridges. Use respirators and components tested and approved
under appropriate government standards such as NIOSH (US) or CEN (EU).
e) Melting 238 °C
point/freezing point
f) Initial boiling point No data available
and boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, No data available
gas)
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure 20 hPa at 89 °C
l) Vapour density No data available
m) Relative density 1,230 g/cm3 at 18 °C
n) Water solubility 18,7 g/l at 16 °C
o) Partition coefficient: log Pow: -0,091 at 23 °C
n-octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
9.2 Other safety information
Bulk density 220 kg/m3
Dissociation constant 10,4 at 40 °C
Mouse - male
Result: negative
(ECHA)
Human
Result: negative
(ECHA)
Mouse - male
Result: negative
(ECHA)
OECD Test Guideline 474
Mouse - male and female - Red blood cells (erythrocytes)
Result: Positive results were obtained in some in vivo tests.
Carcinogenicity
IARC: 3 - Group 3: Not classifiable as to its carcinogenicity to humans (Caffeine)
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
Repeated dose toxicity - Mouse - male and female - Oral - 90 d - No observed adverse
effect level - 167,4 - 179,4 mg/kg
(ECHA)
RTECS: EV6475000
To the best of our knowledge, the chemical, physical, and toxicological properties have not
been thoroughly investigated.
After absorption of toxic quantities:
Diarrhoea, Vomiting, agitation, Headache
Systemic effects:
drop in blood pressure, tachycardia
Handle in accordance with good industrial hygiene and safety practice.
Liver - Irregularities - Based on Human Evidence
The branding on the header and/or footer of this document may temporarily not visually
match the product purchased as we transition our branding. However, all of the
information in the document regarding the product remains unchanged and matches the
product ordered. For further information please contact [email protected].